252 related articles for article (PubMed ID: 1803376)
1. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].
Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
Probl Tuberk; 1991; (12):52-4. PubMed ID: 1803376
[TBL] [Abstract][Full Text] [Related]
2. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
[No Abstract] [Full Text] [Related]
3. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
Ivanova LA
Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
[TBL] [Abstract][Full Text] [Related]
4. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
[No Abstract] [Full Text] [Related]
5. [Immunotherapy of pulmonary tuberculosis].
Khudzik LB; Salina TIu; Parolina LE
Probl Tuberk; 1998; (6):23-6. PubMed ID: 10067345
[TBL] [Abstract][Full Text] [Related]
6. [Effect of thymagen, thymalin and vilosen on the cAMP and cGMP levels and phosphodiesterase activity in spleen lymphocytes during sensitization and anaphylactic shock].
Demidov SV; Kostromin AN; Kuĭbeda VV; Chernaia IV; Borovok MI
Ukr Biokhim Zh (1978); 1991; 63(4):104-6. PubMed ID: 1659006
[TBL] [Abstract][Full Text] [Related]
7. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
Sov Med; 1990; (6):111-3. PubMed ID: 2144365
[No Abstract] [Full Text] [Related]
8. [Effect of thymus polypeptide fractions on the development of rat thymus and spleen in organ culture].
Chalisova NI; Khavinson VKh; Penniiaĭnen VA; Grigor'ev EI
Tsitologiia; 1999; 41(10):889-94. PubMed ID: 10591126
[TBL] [Abstract][Full Text] [Related]
9. [Radiation protective effect of low molecular weight thymus preparations].
Baraboĭ VA; Ialkut SI; Savtsova ZD; Zinchenko VA; Zhukova VM; Zaritskaia MIu
Radiats Biol Radioecol; 1994; 34(4-5):663-70. PubMed ID: 7951900
[TBL] [Abstract][Full Text] [Related]
10. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
Chukanov VI; Gergert VIa; Khomenko IS
Probl Tuberk; 1989; (6):30-3. PubMed ID: 2771908
[TBL] [Abstract][Full Text] [Related]
12. [The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis].
Medus AI; Pisarevskaia LI; Nikishina EV
Voen Med Zh; 1999 Oct; 320(10):65-7, 96. PubMed ID: 10605346
[TBL] [Abstract][Full Text] [Related]
13. [Thymic polypeptide factor--thymalin in experiments and in clinical use].
Sofronov BN; Morozov VG; Khavinson VKh; Belokrylov GA
Fiziol Cheloveka; 1984; 10(2):229-33. PubMed ID: 6335878
[No Abstract] [Full Text] [Related]
14. Influence of thymic preparations on the result of experimental infection with Taenia crassiceps (Zeder, 1800) in ICR mice.
Hermánek J; Prokopic J
Folia Parasitol (Praha); 1989; 36(4):331-40. PubMed ID: 2488049
[TBL] [Abstract][Full Text] [Related]
15. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
Iakhontova OI; Dudanova OP; Khavinson VKh
Sov Med; 1990; (6):85-8. PubMed ID: 2396134
[No Abstract] [Full Text] [Related]
16. [The electrophoretic mobility of peripheral blood lymphocytes in patients with tuberculosis of the lungs].
Skvortsova RG; Nikitina OI
Probl Tuberk; 1990; (5):11-4. PubMed ID: 2388887
[TBL] [Abstract][Full Text] [Related]
17. [Effect of thymic immunomodulators on the system of cyclic nucleotides of splenic T-lymphocytes after BCG vaccination].
Demidov SV; Kostromin AP; Chernyshenko EF; Kuĭbeda VV; Borovok MI
Probl Tuberk; 1990; (10):63-5. PubMed ID: 1981933
[TBL] [Abstract][Full Text] [Related]
18. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
[No Abstract] [Full Text] [Related]
19. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
Adambekov DA; Litvinov VI; Mambetov KB; Koshmuratov AG; Sabyrbekova TS
Probl Tuberk; 1998; (5):46-8. PubMed ID: 9866400
[TBL] [Abstract][Full Text] [Related]
20. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
Karachunskiĭ MA; Gergert VIa; Iakovleva OB
Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
